Digest Network Come funziona
Network
/
Società
eG
Non verificato

eGenesis

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

8 comunicati stampa

Guarda tutti i comunicati
24/03/2026
Eventi
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
eGenesis Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
Fonte
eGenesis
Emittente
Business Wire
1.00
0
07/01/2026
Salute
Biotecnologia
Scienza
Farmaceutica
Eventi
eGenesis to Present at 44th Annual J.P. Morgan Healthcare Conference
Fonte
eGenesis
Emittente
Business Wire
1.00
0
08/09/2025
Sanità
Scienza
Farmaceutica
Biotecnologia
Medicina - Varie
Igiene alimentare
Salute
Industria
eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant and Landmark Patient Updates in Ongoing Expanded Access Study
Fonte
eGenesis
Emittente
Business Wire
1.00
0
19/08/2025
Salute
Medicina - Varie
Biotecnologia
Scienza
Mercato del lavoro
eGenesis Appoints Douglas Williams, Ph.D., and Adam Craig, M.D., Ph.D., to its Board of Directors
Fonte
eGenesis
Emittente
Business Wire
1.00
0
06/05/2025
eGenesis Appoints Dr. Jay Barth as Chief Medical Officer
Fonte
eGenesis
Emittente
Business Wire
1.00
0
15/04/2025
Multimedialità
Industria
Sanità
Scienza
Farmaceutica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Igiene alimentare
Salute
eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for the Treatment of Patients with Acute-On-Chronic Liver Failure
Fonte
eGenesis
Emittente
Business Wire
1.00
0
07/02/2025
eGenesis Announces Second Patient Successfully Transplanted with Genetically Engineered Porcine Kidney
Fonte
eGenesis
Emittente
Business Wire
1.00
0
04/09/2024
Multimedialità
Scienza
Medicina - Varie
Sanità
Biotecnologia
Salute
eGenesis Raises $191 Million Series D Financing to Advance Lead Program for Kidney Transplant
Fonte
eGenesis
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0